C. Randal Mills, the 45-year-old CEO of California’s $3 billion stem cell research program, is a man who loves his milestones. A private pilot, he charts his course in the air from one specific point to the next. Three years ago, Mills brought that same sort of navigation to the state stem cell agency.
Pharmaceuticals and money -- elements in the debate over a cost-disclosure bill. (Photo: O.S. Fisher, Shutterstock)
An attempt to force drug makers to disclose their costs and profits for drugs that sell wholesale for more than $10,000 annually was derailed in the Legislature, facing strong opposition from an industry targeting similar measures in other states. The forces battling over the bill include some of the most powerful in California.